Coumarin.
D000818:Animals; D000925:Anticoagulants / Q000009:adverse effects* / Q000032:analysis / Q000737:chemistry / Q000378:metabolism; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000032:analysis / Q000737:chemistry / Q000378:metabolism; D015197:Carcinogenicity Tests; D003374:Coumarins / Q000009:adverse effects* / Q000032:analysis / Q000737:chemistry / Q000378:metabolism; D006224:Cricetinae; D004195:Disease Models, Animal; D004781:Environmental Exposure / Q000009:adverse effects* / Q000032:analysis; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D009374:Neoplasms, Experimental / Q000139:chemically induced; D051381:Rats; D012098:Reproduction / Q000187:drug effects
D000925:Anticoagulants; D000970:Antineoplastic Agents; D003374:Coumarins